Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10514)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2014 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao HQ, Li WM, Lu ZQ, Yao YM. Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(24): 7971-7978 [PMID: 24976734 DOI: 10.3748/wjg.v20.i24.7971] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i24/7971.htm |
| Number | Citing Articles |
| 1 |
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(1): 1-18 doi: 10.4251/wjgo.v15.i1.1
|
| 2 |
Lejia Sun, Gang Xu, Wenjun Liao, Huayu Yang, Haifeng Xu, Shunda Du, Haitao Zhao, Xin Lu, Xinting Sang, Yilei Mao. Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis. Oncotarget 2017; 8(24): 39658 doi: 10.18632/oncotarget.17340
|
| 3 |
Luigi Buonaguro, Maria Tagliamonte, Annacarmen Petrizzo, Elvira Damiano, Maria Lina Tornesello, Franco M Buonaguro. Cellular prognostic markers in hepatocellular carcinoma. Future Oncology 2015; 11(11): 1591 doi: 10.2217/fon.15.39
|
| 4 |
Nashwa Abd El-Aziz, Ghada El Gohary, Sherif Mohamed, Khaled El-Saleh. Lymphocytes. 2019; doi: 10.5772/intechopen.79168
|
| 5 |
Astha Malik, Unmesha Thanekar, Surya Amarachintha, Reena Mourya, Shreya Nalluri, Alexander Bondoc, Pranavkumar Shivakumar. “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.627701
|
| 6 |
Zurabi Lominadze, Kareen Hill, Mohammed Rifat Shaik, Justin P. Canakis, Mohammad Bourmaf, Cyrus Adams-Mardi, Ameer Abutaleb, Lopa Mishra, Kirti Shetty. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review. International Journal of Molecular Sciences 2023; 24(3): 2358 doi: 10.3390/ijms24032358
|
| 7 |
Yuping D. Li, Dorina Veliceasa, Jason B. Lamano, Jonathan B. Lamano, Gurvinder Kaur, Dauren Biyashev, Craig M. Horbinski, Tim J. Kruser, Orin Bloch. Systemic and local immunosuppression in patients with high-grade meningiomas. Cancer Immunology, Immunotherapy 2019; 68(6): 999 doi: 10.1007/s00262-019-02342-8
|
| 8 |
Zhi‐Qin Li, Hong‐Yan Wang, Qing‐Lei Zeng, Jing‐Ya Yan, Yu‐Shu Hu, Hua Li, Zu‐Jiang Yu. p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma. Cancer Medicine 2020; 9(2): 711 doi: 10.1002/cam4.2611
|
| 9 |
Bettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, Annekristin Hausen, Leona Dold, Peer van Heteren, Robert Hüneburg, Jacob Nattermann, Christian P. Strassburg, Ulrich Spengler. Increased peripheral CD4 + regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C. Journal of Hepatology 2017; 66(5): 888 doi: 10.1016/j.jhep.2016.12.019
|
| 10 |
SiZhe Yu, Yu Wang, Jia Hou, WenYuan Li, Xiao Wang, LuoChengLing Xiang, DeLi Tan, WenJuan Wang, LiLi Jiang, Francois X. Claret, Min Jiao, Hui Guo, Edwin Wang. Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival. PLOS ONE 2020; 15(4): e0231003 doi: 10.1371/journal.pone.0231003
|
| 11 |
A. Petrizzo, A. Mauriello, M. L. Tornesello, F. M. Buonaguro, M. Tagliamonte, L. Buonaguro. Cellular prognostic markers in hepatitis-related hepatocellular carcinoma. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0183-8
|
| 12 |
Zhongqin Gong, Jianqing Yu, Shucai Yang, Paul B.S. Lai, George G. Chen. FOX transcription factor family in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188376 doi: 10.1016/j.bbcan.2020.188376
|
| 13 |
David A. G. Skibinski, Leigh Ann Jones, Yuan O. Zhu, Lin Wu Xue, Bijin Au, Bernett Lee, Ahmad Nazri Mohamed Naim, Audrey Lee, Nivashini Kaliaperumal, Jenny G. H. Low, Lawrence S. Lee, Michael Poidinger, Philippe Saudan, Martin Bachmann, Eng Eong Ooi, Brendon J. Hanson, Veronica Novotny-Diermayr, Alex Matter, Anna-Marie Fairhurst, Martin L. Hibberd, John E. Connolly. Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-36703-7
|
| 14 |
Nam-Chul Jung, Jun-Ho Lee, Hyun-Ji Choi, Sung-Uk Hwang, Jie-Young Song, Han Geuk Seo, Jinjung Choi, Sang Youn Jung, Sung Gu Han, Dae-Seog Lim. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice. Immunological Investigations 2016; 45(6): 553 doi: 10.1080/08820139.2016.1183025
|
| 15 |
Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai-Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan, Pierce Kah-Hoe Chow, Han Chong Toh, Seng Gee Lim, Qingfeng Chen. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut 2018; 67(10): 1845 doi: 10.1136/gutjnl-2017-315201
|
| 16 |
Zeev Elkoshi. <p>“High Treg” Inflammations Promote (Most) Non-Hematologic Cancers While “Low Treg” Inflammations Promote Lymphoid Cancers</p>. Journal of Inflammation Research 2020; : 209 doi: 10.2147/JIR.S249384
|
| 17 |
Tristan A Barnes, Eitan Amir. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. British Journal of Cancer 2017; 117(4): 451 doi: 10.1038/bjc.2017.220
|
| 18 |
Pierpaolo Biondetti, Lorenzo Saggiante, Anna Maria Ierardi, Massimo Iavarone, Angelo Sangiovanni, Filippo Pesapane, Enrico Maria Fumarola, Pietro Lampertico, Gianpaolo Carrafiello. Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC. Cancers 2021; 13(22): 5797 doi: 10.3390/cancers13225797
|
| 19 |
Kai Wen Huang, Kumar Jayant, Po-Huang Lee, Po-chih Yang, Chih-Yang Hsiao, Nagy Habib, Mikael H. Sodergren. Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma. Journal of Clinical Medicine 2019; 8(3): 385 doi: 10.3390/jcm8030385
|
| 20 |
Kurt Sartorius, Leo Swadling, Ping An, Julia Makarova, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020; 12(7): 746 doi: 10.3390/v12070746
|
| 21 |
Xinhua Zou, Qingyu Xu, Ran You, Guowen Yin. Correlation and efficacy of TACE combined with lenvatinib plus PD‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features. Cancer Medicine 2023; 12(10): 11315 doi: 10.1002/cam4.5841
|
| 22 |
Hyo-Jung Cho, Jae-Youn Cheong. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(15): 8011 doi: 10.3390/ijms22158011
|
| 23 |
Suresh Gopi Kalathil, Yasmin Thanavala. High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy. Cancer Immunology, Immunotherapy 2016; 65(7): 813 doi: 10.1007/s00262-016-1810-0
|
| 24 |
Weili Jia, Tianchen Zhang, Qianyun Yao, Jianhui Li, Ye Nie, Xinjun Lei, Zhenzhen Mao, Yanfang Wang, Wen Shi, Wenjie Song. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.870458
|
| 25 |
Ji Won Han, Pil Soo Sung, Seon-Hui Hong, Hoyoung Lee, June Young Koh, Hyojin Lee, Scott White, Joel N. Maslow, David B. Weiner, Su-Hyung Park, Moonsup Jeong, Jeong Heo, Sang Hoon Ahn, Eui-Cheol Shin. IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses. Journal of Hepatology 2020; 73(1): 72 doi: 10.1016/j.jhep.2020.02.009
|
| 26 |
Mona Abd El-Rahman Abu El-Makarem, Douaa Mohammed Sayed, Ragaa Abdelshaheed Matta, Mahmoud Ragab Mohamed, Manal Ameer Abd El-Malak, Nehal Ibrahim Abbas. Interaction of peripheral CD4+CD25+CD127− Tregs with prolactin in HCV hepatocellular carcinoma: oncogenic or immunogenic mechanisms. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00250-2
|
| 27 |
Martin F. Sprinzl, Peter R. Galle. Immune Control in Hepatocellular Carcinoma Development and Progression: Role of Stromal Cells. Seminars in Liver Disease 2014; 34(04): 376 doi: 10.1055/s-0034-1394138
|
| 28 |
Deliang Huang, Dejing Huang. Relationship between M6A methylation regulator and prognosis in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. Heliyon 2022; 8(10): e10931 doi: 10.1016/j.heliyon.2022.e10931
|
| 29 |
Gang Ning, Yan-Lin Huang, Li-Min Zhen, Wen-Xiong Xu, Xue-Jun Li, Li-Na Wu, Ying Liu, Chan Xie, Liang Peng, Tao Huang. Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/3765937
|
| 30 |
Joseph M. Obeid, Paul R. Kunk, Victor M. Zaydfudim, Timothy N. Bullock, Craig L. Slingluff, Osama E. Rahma. Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?. Cancer Immunology, Immunotherapy 2018; 67(2): 161 doi: 10.1007/s00262-017-2082-z
|
| 31 |
Wojciech Jóźwicki, Anna A. Brożyna, Jerzy Siekiera, Andrzej T. Slominski. Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal. Oncotarget 2016; 7(10): 11450 doi: 10.18632/oncotarget.7199
|
| 32 |
Arshi Khanam, Shyam Kottilil. New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 2022; 24(1): 437 doi: 10.3390/ijms24010437
|
| 33 |
N. Trehanpati, A. K. Vyas. Immune Regulation by T Regulatory Cells in Hepatitis B Virus‐Related Inflammation and Cancer. Scandinavian Journal of Immunology 2017; 85(3): 175 doi: 10.1111/sji.12524
|
| 34 |
Haoran Sun, Zepeng Cao, Baochen Zhao, Dachen Zhou, Zhongbiao Chen, Bin Zhang. An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03940-w
|
| 35 |
Haidi Karam-Allah Ramadan, Gamal Badr, Nancy K Ramadan, Aml Sayed. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study. Pathogens and Disease 2021; 79(3) doi: 10.1093/femspd/ftab008
|
| 36 |
Weili Jia, Qianyun Yao, Yanfang Wang, Zhenzhen Mao, Tianchen Zhang, Jianhui Li, Ye Nie, Xinjun Lei, Wen Shi, Wenjie Song. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1007426
|
| 37 |
Peipei Xu, Wei Fan, Zheng Zhang, June Wang, Ping Wang, Yirong Li, Mingxia Yu. The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis. Frontiers in Physiology 2017; 8 doi: 10.3389/fphys.2017.00950
|
| 38 |
Kurt Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Xiaodong Li, Julia Makarova, Anna Kramvis. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661204
|
| 39 |
Junyu Huo, Liqun Wu, Yunjin Zang, Hongjing Dong, Xiaoqiang Liu, Fu He, Xiao Zhang. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07734-z
|
| 40 |
Xiaojun Su, Xiuli Yan, Hui Zhang. The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine. Molecular Cancer 2025; 24(1) doi: 10.1186/s12943-025-02378-8
|
| 41 |
Gaetano Bertino, Shirin Demma, Annalisa Ardiri, Maria Proiti, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Michele Malaguarnera. The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/731469
|
| 42 |
Kumar Jayant, Nagy Habib, Kai W. Huang, Jane Warwick, Ramesh Arasaradnam. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics 2020; 10(5): 338 doi: 10.3390/diagnostics10050338
|
| 43 |
Alip Ghosh, Sara Romani, Shyam Kottilil, Bhawna Poonia. Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal. International Journal of Molecular Sciences 2020; 21(20): 7473 doi: 10.3390/ijms21207473
|
| 44 |
Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, Alexander Lim, Richard Kim. Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?. Cancers 2019; 11(8): 1078 doi: 10.3390/cancers11081078
|
| 45 |
Chun-Hui Yuan, Xiao-Ming Sun, Cheng-Liang Zhu, Shao-Ping Liu, Long Wu, Hao Chen, Mao-Hui Feng, Ke Wu, Fu-Bing Wang. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells. Oncotarget 2015; 6(31): 32138 doi: 10.18632/oncotarget.5171
|
| 46 |
Renumathy Dhanasekaran, Salome Bandoh, Lewis R. Roberts. Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Research 2016; 5: 879 doi: 10.12688/f1000research.6946.1
|
| 47 |
Landon L. Chan, Stephen L. Chan. Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinoma. Expert Opinion on Emerging Drugs 2021; 26(1): 39 doi: 10.1080/14728214.2021.1902503
|
| 48 |
Raphaël Jost, Nael Al-Shatti, Mario Ghosn, Baptiste Bonnet, Stephane Champiat, Frederic Deschamps, Maximiliano Gelli, Valérie Boige, Francois-Xavier Danlos, Sandrine Susini, Antoine Hollebecque, Samy Ammari, Aurelien Marabelle, Thierry de Baere, Lambros Tselikas. Synergizing liver systemic treatments with interventional oncology: friend or foe?. The British Journal of Radiology 2022; 95(1138) doi: 10.1259/bjr.20220548
|
| 49 |
Stephen P Hack, Jessica Spahn, Minshan Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Pierce Chow, Shukui Qin. IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation. Future Oncology 2020; 16(15): 975 doi: 10.2217/fon-2020-0162
|
| 50 |
Yunxiu Luo, Ziyi Wang, Shengjun Xiao, Ruirui Li, Xiaoshan Jiang, Wen-Jun Tu. G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/2628879
|
| 51 |
Manali Dimri, Ande Satyanarayana. Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma. Cancers 2020; 12(2): 491 doi: 10.3390/cancers12020491
|